Does knowledge of the mutation in hereditary long QT syndrome aid risk stratification?
Eur Heart J
.
2021 Dec 7;42(46):4756-4758.
doi: 10.1093/eurheartj/ehab668.
Author
Andrew Tinker
1
Affiliation
1
Centre for Clinical Pharmacology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
PMID:
34542608
PMCID:
PMC8651157
DOI:
10.1093/eurheartj/ehab668
No abstract available
Publication types
Editorial
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Humans
Long QT Syndrome* / genetics
Mutation / genetics
Risk Assessment
Grants and funding
FS/16/30/32162/BHF_/British Heart Foundation/United Kingdom
DH_/Department of Health/United Kingdom
MRC_/Medical Research Council/United Kingdom